Harvard Business Review

MARCH 13, 2012

Opponents will point out that the discovery of oil and gas can explain a lot of North Dakota's recent success. And of course that's true — but the commodities market has been booming only in recent years, and the bank's track record is long and impressive. Our 50 states have been called laboratories of democracy.

Biotechnology 10

Biotechnology Real Estate Tourism Banking 10

Harvard Business Review

MARCH 2, 2012

HBS welcomes 6,360 foreign nationals (64% of the total) to its executive education courses each year, enriching the experiences for Americans as well. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

DECEMBER 30, 2011

Organizations invest billions annually on a success curriculum known as "leadership development," which ends up leaving so much on the table. In other words, what if cultivating a successful inner life was front and center on the leadership agenda? Developing people is a process — not an event.

Development 17

Development Biotechnology CIO Short-term 17

Harvard Business Review

FEBRUARY 22, 2013

Years of development, energy, and, of course, money have gone into it. Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. Your company has just developed an amazing new product. Hype and excitement behind the launch pushes it into high gear. What do you do next?

Productivity 8

Productivity Products Biotechnology IPO 8

Harvard Business Review

MAY 10, 2016

In the course of research for our book , we’ve found that this approach also provides an ideal methodology for leaders to identify which M&A deals are most likely to pay off — a disciplined approach that acts as a kind of lens for effectively distinguishing gold from iron pyrite in assessing potential company synergies.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. This was a notable success — but what if we combined the insights and resources of a life science company and health provider that were both focused on, say, acute cardiovascular diseases?

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Tanveer Naseer

OCTOBER 20, 2015

You have the power to bring someone from the slums of life and make a successful person out of them, or destroy someone’s happiness using only your words. With a record like his, it’s not surprising that many people try to use his tactics in the hopes of getting a taste of the levels of success he’s achieved.

Power 100

Power Long-term Uncertainty Biotechnology 100

Harvard Business Review

FEBRUARY 19, 2015

Clark recommends listing the “concrete skills you need to develop in order to be successful at pursuing your passion full-time.” ” It’s a question only you can answer, of course. “If you’re cash-rich and time-poor, look for opportunities to trade money for time,” he says. Patch weak spots.

Project 8

Project Outsourcing Learning-by-Doing Commitment 8

Harvard Business Review

FEBRUARY 3, 2015

Even the most naive of them agree that, like it or not, relationships hold the key to both their current capac­ity and future success. But just because you know that a network is important to your success, it doesn’t mean you are devoting sufficient time and energy to making it useful and strong. In fact, few of us do.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

MARCH 17, 2014

This question is hard to answer because, in the midst of all of this excitement, there aren’t clear success markers for the sector. Second, in addition to time, the sector needs a framework to measure success, one that makes sense of the sector’s inherent diversity. Surely we can do the same for impact investing.

Development 8

Development Microfinance Biotechnology Exit Strategy 8

Harvard Business Review

AUGUST 4, 2016

Women, of course, are not the only group to experience stereotype threat. This minefield exists because success in business and the professions — being perceived as a leader, effective negotiator, strong advocate, and keen evaluator — involves performing tasks associated with positive male stereotypes and negative female ones.

Stress 8

Stress Biotechnology Self-aware Resources 8

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. To account for its success, many point to America’s entrepreneurial culture, its tolerance for failure and its unique ecosystem of venture funding.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

JULY 22, 2015

” Hanguk was a large, fast-growing company with diversified interests spanning electronics, biotechnology, shipping, construction, and chemicals. Its most successful division, mobile telephony, was looking for a new head of software development at headquarters in Seoul. You’ll be getting the official e-mail from HR soon.”

Case Study 8

Case Study Career Biotechnology Course 8

Harvard Business Review

MARCH 30, 2017

Of course, there is a ways to go, but progress has been made. We worked with a startup biotechnology company. The successful team had much higher cognitive diversity. Looking at the executive teams we work with as consultants and those we teach in the classroom, increased diversity of gender, ethnicity, and age is apparent.

Diversity 8

Diversity Team Biotechnology Execution 8